BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Health Issues HCR

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee 340B Drug Discount Program ---Executive Order on Access to Affordable Life-Saving Medications ---Program Implementation & Oversight Antibiotic & Diagnostic Tax Credit Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of Medical Countermeasure Innovation Act of 2016 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---National Biodefense Strategy Biosimilars ---BSUFA ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2017 Coronavirus (COVID-19) Pandemic ---H.R.869/S.289: Research Investment to Spark the Economy (RISE) Act of 2021 ---H.R.1319: American Rescue Plan Act of 2021 ------Funding Allocation from HHS to BARDA for Therapeutics ------Funding for Vaccine Distribution ------Funding for Vaccine Hesitancy ---DISARM Act (Discussion Draft) ---COVID-19 Lessons Learned ---COVID-19 Pricing-Related Provisions ---COVID-19 Vaccine Distribution ---Defense Production Act (DPA) ---Drug Supply Chain Management ---Healthcare Disparities ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---In-Home Administration of Part B Drugs ---Medicare Reimbursement Policies ---Monoclonal Antibody Coverage and Utilization ---Patient Cost-Sharing and Smoothing ---R&D Funding for Medical Countermeasures ---Restrictions on Intellectual Property Rights ---Small Business Loans ---Temporarily Refundable R&D Credit Diagnostics and Personalized Medicine Regulation and Oversight ---VALID Act (Discussion Draft) Diversity & Inclusion ---H.R.1319: American Rescue Plan Act of 2021 ---Clinical Trial Diversity Drug Evaluation and Review ---COVID-19 Lessons Learned ---Expedited Pathways ---FDA Hiring Flexibility ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Innovation Incentives ---Prescription Drug User Fee Act (PDUFA) VII Priorities ---Use of Real-World Evidence Drug Importation ---S.920: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. Drug Manufacturing, Quality & Distribution ---H.R.1319: American Rescue Plan Act of 2021 ------Funding for Vaccine Distribution ---A bill to amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment. (Discussion Draft) ---Drug Shortages ---Executive Order on Buy American ---Supply Chain Integrity and Traceability Drug Patenting ---H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021 ---Affordable Prescriptions for Patients Act (Discussion Draft) ---Lower Costs, More Cures Act (Discussion Draft) ---Medicare Negotiation and Competitive Licensing Act (Discussion Draft) ---Restrictions on Intellectual Property Rights Drug Pricing ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---S.908: A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. ---S.909: A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries. ---Lower Costs, More Cures Act (Discussion Draft) ---Lower Drug Costs Now Act (Discussion Draft) ---Medicare Prescription Drug Price Negotiation Act (Discussion Drafts) ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) ---CMMI Authority ---COVID-19 Pricing-Related Provisions ---Drug Pricing Provisions ---Reference Pricing in Drug Reimbursement Funding for Antimicrobial Resistance Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act (Discussion Draft) ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for FDA ---FY 2022 Appropriations ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) - 340B Program Integrity Issues ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 Funding for Health Resources and Services Administration (HRSA) - Countermeasures Injury Compensation Program (CICP) ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 Funding for Health Resources and Services Administration (HRSA) - Vaccine Injury Compensation Program (VICP) ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 Funding for National Institutes of Health ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for 2020-2021 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---FY 2022 Appropriations Medicaid ---H.R.133: Consolidated Appropriations Act for FY 2021 ---Alternative payment arrangements for gene therapies ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates ---Value-Based Purchasing (VBP) Rule Opioid Crisis ---FDA Reforms Orphan Drug Issues ---Tax Credit Reimbursement and Coverage of Innovative Products ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---S.908: A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. ---S.909: A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries. ---Lower Costs, More Cures Act (Discussion Draft) ---Lower Drug Costs Now Act (Discussion Draft) ---Administration Rebate Rule ---CMMI Authority ---Drug Pricing Provisions ---Medicare Part B Physician-Administered Products ---Protected Classes ---Reference Pricing in Drug Reimbursement ---Value-Based Purchasing (VBP) Rule Vaccines and Infectious Diseases ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ------Funding for Vaccine Distribution ------Funding for Vaccine Hesitancy ---DISARM Act (Discussion Draft) ---Protecting Seniors through Immunizations Act (Discussion Draft) ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act (Discussion Drafts) ---Adult Immunization ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---Maternal Immunization ---MCM Manufacturing & Capacity ---MCM R&D Incentives ---Monoclonal Antibody Coverage and Utilization ---Vaccine Injury Compensation Program ---Vaccine Quality Measure ---Vaccine Safety ---Vaccine and Antimicrobial Resistance Product Development and Incentives Vaccine Injury Compensation Program Tax ---FY 2022 Appropriations ---Vaccine Access Improvement Act (Discussion Draft) ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; White House Office; Natl Institute of Standards & Technology (NIST); SENATE

Bills named: H.R. 1319 (117th), H.R. 869 (117th), S. 289 (117th), S. 909 (117th), H.R. 133 (117th), S. 908 (117th), S. 920 (117th), H.R. 153 (117th)

Animals ANI

Genetically Engineered (GE) Animals ---H.R.133: Consolidated Appropriations Act for FY 2021 ------GE Salmon ---H.R.1319: American Rescue Plan Act of 2021 ------Funding the monitoring of COVID-19 in animals ------Supporting Farmers and Strengthening the Food Supply Chain ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------Feed Additives ------GE Salmon ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Efficient Science-Based Review of Biotech Products ---FDA Approval ---FDA Proposed Guidance on Gene Editing ---FDA Regulatory Approach to Animal Biotechnology ---International Consistency of Regulation for Gene Edited Products ---Labeling ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering Review and Labeling of Food Derived from Biotechnology ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------GE Salmon ---Implementation of Disclosure Law

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Natl Institute of Standards & Technology (NIST); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 133 (117th), H.R. 1319 (117th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit Biomass Programs (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Biorefineries (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Climate Change ---FY 2022 Appropriations ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Fighting Climate Change through Biotechnology Innovation Funding for Biofuels ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for Biomass Crop Assistance Program ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for Biorefineries ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Renewable Fuel Standard (RFS) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Cellulosic Registration Applications for Corn Kernel Fiber ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Economic Hardship Waiver of the Renewable Volume Obligations (RVO) for 2020 ---RFS Reform ---Small Refinery Waivers

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Natl Institute of Standards & Technology (NIST); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Commerce, Dept of (DOC)

Bills named: H.R. 1512 (117th), S. 218 (117th), H.R. 1113 (117th), H.R. 1319 (117th), S. 193 (117th), S.Con.Res. 5 (117th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of Medical Countermeasure Innovation Act of 2016 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---National Biodefense Strategy Funding for Antimicrobial Resistance (AMR) Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act (Discussion Drafts) ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020

Contacted: Office of Management & Budget (OMB); Natl Institute of Standards & Technology (NIST); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); White House Office; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of Medical Countermeasure Innovation Act of 2016 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---National Biodefense Strategy Coronavirus (COVID-19) Pandemic ---H.R.1319: American Rescue Plan Act of 2021 ------Funding Allocation from HHS to BARDA for Therapeutics ------Funding for Vaccine Distribution ------Funding for Vaccine Hesitancy ---Temporarily Refundable R&D Credit Funding for Antimicrobial Resistance (AMR) Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act (Discussion Drafts) ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for National Institutes of Health ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for 2020-2021 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020

Contacted: Health & Human Services, Dept of (HHS); White House Office; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institute of Standards & Technology (NIST); SENATE; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Bills named: H.R. 133 (117th), H.R. 1319 (117th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit Biomass Programs (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Biorefineries (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Climate Change ---FY 2022 Appropriations ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Fighting Climate Change through Biotechnology Innovation Funding for Biofuels ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for Biomass Crop Assistance Program ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for Biorefineries ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Renewable Fuel Standard (RFS) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Cellulosic Registration Applications for Corn Kernel Fiber ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Economic Hardship Waiver of the Renewable Volume Obligations (RVO) for 2020 ---RFS Reform ---Small Refinery Waivers

Contacted: Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Natl Institute of Standards & Technology (NIST); Patent & Trademark Office (PTO); SENATE

Bills named: S.Con.Res. 5 (117th), S. 218 (117th), H.R. 1113 (117th), H.R. 1512 (117th), S. 193 (117th), H.R. 1319 (117th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---H.R.133: Consolidated Appropriations Act for FY 2021 ------GE Salmon ---H.R.1319: American Rescue Plan Act of 2021 ------Funding the monitoring of COVID-19 in animals ------Supporting Farmers and Strengthening the Food Supply Chain ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------Feed Additives ------GE Salmon ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Efficient Science-Based Review of Biotech Products ---FDA Approval ---FDA Proposed Guidance on Gene Editing ---FDA Regulatory Approach to Animal Biotechnology ---International Consistency of Regulation for Gene Edited Products ---Labeling ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering Review and Labeling of Food Derived from Biotechnology ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------GE Salmon ---Implementation of Disclosure Law

Contacted: Office of Management & Budget (OMB); SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Institute of Standards & Technology (NIST); U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Commerce, Dept of (DOC)

Bills named: H.R. 1319 (117th), H.R. 133 (117th)

Trade (domestic/foreign) TRD

Digital Trade ---EU Digital Strategy Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Korea Biotechnology Regulations ---Mexico Draft Decree Banning Genetically Modified Corn ---Mexico Import Approval Delays of Ag Biotech Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Mexico ---TRIPS Waiver The United States-Mexico-Canada Agreement (USMCA) ---Ag-Biotech Provisions ---Implementation of United States-Mexico-Canada Agreement (USMCA) ---Mexico Draft Decree Banning Genetically Modified Corn US-China Trade Agreement ---Ag-Biotech Provisions ---IP Provisions US-EU Trade Agreement ---Ag-Biotech Provisions World Trade Organization ---E-Commerce Negotiations ---TRIPS Waiver World Health Organization (WHO) ---United States Withdrawal from the World Health Organization (WHO)

Contacted: Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); SENATE; Natl Institute of Standards & Technology (NIST); Commerce, Dept of (DOC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); White House Office

Agriculture AGR

Climate Change ---FY 2022 Appropriations ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Fighting Climate Change through Biotechnology Innovation Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Korea Biotechnology Regulations ---Mexico Draft Decree Banning Genetically Modified Corn ---Mexico Import Approval Delays of Ag Biotech Funding for the USDA ---H.R.1319: American Rescue Plan Act of 2021 ------Funding the monitoring of COVID-19 in animals ------Supporting Farmers and Strengthening the Food Supply Chain ------Ensuring Equity for Farmers of Color Amid the Pandemic ---S.278: Emergency Relief for Farmers of Color Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding Genetically Engineered (GE) Animals ---H.R.133: Consolidated Appropriations Act for FY 2021 ------GE Salmon ---H.R.1319: American Rescue Plan Act of 2021 ------Funding the monitoring of COVID-19 in animals ------Supporting Farmers and Strengthening the Food Supply Chain ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------Feed Additives ------GE Salmon ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Efficient Science-Based Review of Biotech Products ---FDA Approval ---FDA Proposed Guidance on Gene Editing ---FDA Regulatory Approach to Animal Biotechnology ---International Consistency of Regulation for Gene Edited Products ---Labeling ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering Genetically Engineered (GE) Plants ---Climate Issues & impact on the agriculture, food, and forestry sectors ---EPA Regulatory Approach to Gene Editing ---EPA proposed revisions to regulations related to the oversight of certain plant-incorporated protectants (PIPs) ---FDA Proposed Guidance on Gene Editing ---International Consistency of Regulation for Gene Edited Products Review and Labeling of Food Derived from Biotechnology ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------GE Salmon ---Implementation of Disclosure Law USDA/APHIS Agricultural Biotechnology Regulations ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Regulatory Treatment of Gene Edited Products ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering

Contacted: Food & Drug Administration (FDA); White House Office; SENATE; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institute of Standards & Technology (NIST); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 278 (117th), H.R. 1319 (117th), H.R. 133 (117th)

Taxation/Internal Revenue Code TAX

Antibiotic & Diagnostic Tax Credit Biofuels (Non-Funding) ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---Incentives for Sustainable Aviation Fuels ---Sustainable Aviation Fuels Tax Credit Capital Formation Incentives ---A bill to amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities (Discussion Draft) ---A bill to amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research. (Discussion Draft) ---American Innovation Act (Discussion Drafts) ---IGNITE American Innovation Act (Discussion Drafts) ---Infectious Disease Therapies Research and Innovation Act (Discussion Draft) ---Incentives for Sustainable Aviation Fuels ---Proposed amendments under the Exchange Act of 1934 ---Proposed amendments under the Investment Company Act of 1940 ---Proposed amendments under the Securities Act of 1933 ---Reform of Net Operating Loss Rules Coronavirus (COVID-19) Pandemic ---Bringing Back American Jobs Through Intellectual Property Repatriation Act (Discussion Draft House) ---Coronavirus Emerging Growth Companies (EGC) Extension Act (Discussion Draft) ---IGNITE American Innovation Act (Discussion Drafts) ---Temporarily Refundable R&D Credit Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---Investment Tax Credit ---Production Tax Credit Research & Development Tax Credit Reforms ---A bill to amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment. (Discussion Draft) ---American Innovation and Competitiveness Act (AICA) (Discussion Draft) ---Expensing of R&D Expenditures ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---R&D Payroll Credit Vaccine Injury Compensation Program Tax ---Vaccine Access Improvement Act (Discussion Draft) ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Families First Coronavirus Response Act of 2020

Contacted: Office of Management & Budget (OMB); Natl Institute of Standards & Technology (NIST); White House Office; SENATE; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1512 (117th)

Copyright/Patent/Trademark CPT

Antitrust Legislation ---S.225: Competition and Antitrust Law Enforcement Reform Act of 2021 Bayh-Dole Act/Tech Transfer ---FY 2022 Appropriations ---Bayh-Dole 40th Anniversary ---Follow Up Discussions about State Attorney General Letter ---March-In Rights ---NIST Proposed Rulemaking on Bayh-Dole Compulsory Licensing ---Prescription Drug Price Relief Act (Discussion Drafts) ---Medicare Negotiation and Competitive Licensing Act (Discussion Draft) ---We Protect American Investment in Drugs Act (Discussion Draft) Coronavirus (COVID-19) Pandemic ---Bringing Back American Jobs Through Intellectual Property Repatriation Act (Discussion Draft House) ---Restrictions on Intellectual Property Rights Diversity in Patenting ---Implementation of Study of Underrepresented Classes Chasing Engineering and Science Success (SUCCESS) Act of 2018 ---S.632: Inventor Diversity for Economic Advancement (IDEA) Act of 2021 Drug Patenting ---H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021 ---Affordable Prescriptions for Patients Act (Discussion Draft) ---Lower Costs, More Cures Act (Discussion Draft) ---Medicare Negotiation and Competitive Licensing Act (Discussion Draft) ---Restrictions on Intellectual Property Rights Intellectual Property Enforcement ---China ---India ---TRIPS Waiver Inter Partes Review ---Support Technology and Research for Our Nations Growth and Economic Resilience (STRONGER) Patents Act (Discussion Draft) United States-Mexico-Canada Agreement (USMCA) ---Implementation of USMCA US-China Trade Agreement ---IP Provisions

Contacted: SENATE; Natl Institute of Standards & Technology (NIST); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; Office of Management & Budget (OMB); Commerce, Dept of (DOC)

Bills named: S. 632 (117th), S. 225 (117th), H.R. 153 (117th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---FY 2022 Appropriations ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Investment Tax Credit ---Production Tax Credit

Contacted: Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Institute of Standards & Technology (NIST); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Bills named: H.R. 1512 (117th)

Small Business SMB

Capital Formation Incentives ---A bill to amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities (Discussion Draft) ---A bill to amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research. (Discussion Draft) ---American Innovation Act (Discussion Drafts) ---IGNITE American Innovation Act (Discussion Drafts) ---Infectious Disease Therapies Research and Innovation Act (Discussion Draft) ---Incentives for Sustainable Aviation Fuels ---Proposed amendments under the Exchange Act of 1934 ---Proposed amendments under the Investment Company Act of 1940 ---Proposed amendments under the Securities Act of 1933 ---Reform of Net Operating Loss Rules Capital Market Enhancements ---Accredited Investor Definition ---Amended Definition of Smaller Reporting Company ---Market Liquidity Proposals CARES Act Payroll Protection Loan Program Coronavirus (COVID-19) Pandemic ---Coronavirus Emerging Growth Companies (EGC) Extension Act (Discussion Draft) ---IGNITE American Innovation Act (Discussion Drafts) ---Small Business Loans ---Temporarily Refundable R&D Credit Coronavirus (COVID-19) Small Business Loans (Non-Funding) ---Affiliation ---Eligibility ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Payroll Tax Deferral Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions Proxy Advisory Services ---Impact of Policies on Small Public Companies Reform of SEC Regulation D ---Accredited Investor Certification Sarbanes Oxley Section 404 (b) ---Fostering Innovation Act (Discussion Draft) ---Small Issuer Exemption Short Selling Transparency

Contacted: Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Natl Institute of Standards & Technology (NIST); White House Office; HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee Coronavirus (COVID-19) Pandemic ---DISARM Act (Discussion Draft) ---COVID-19 Pricing-Related Provisions ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---In-Home Administration of Part B Drugs ---Patient Cost-Sharing and Smoothing Drug Pricing ---H.R.133: Consolidated Appropriations Act for FY 2021 ---S.908: A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. ---S.909: A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries. ---Lower Costs, More Cures Act (Discussion Draft) ---Lower Drug Costs Now Act (Discussion Draft) ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) ---CMMI Authority ---COVID-19 Pricing-Related Provisions ---Drug Pricing Provisions ---Reference Pricing in Drug Reimbursement Medicaid ---H.R.133: Consolidated Appropriations Act for FY 2021 ---Alternative payment arrangements for gene therapies ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates ---Value-Based Purchasing (VBP) Rule Reimbursement and Coverage of Innovative Products ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---S.908: A bill to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. ---S.909: A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries. ---Lower Costs, More Cures Act (Discussion Draft) ---Lower Drug Costs Now Act (Discussion Draft) ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) ---Administration Rebate Rule ---CMMI Authority ---Drug Pricing Provisions ---Medicare Part B Physician-Administered Products ---Protected Classes ---Reference Pricing in Drug Reimbursement ---Value-Based Purchasing (VBP) Rule Vaccines and Infectious Diseases ---S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---Protecting Seniors through Immunizations Act (Discussion Draft)

Contacted: U.S. Trade Representative (USTR); White House Office; Commerce, Dept of (DOC); SENATE; Natl Institute of Standards & Technology (NIST); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th), S. 908 (117th), H.R. 133 (117th), S. 909 (117th), S. 581 (117th)

Budget/Appropriations BUD

Coronavirus (COVID-19) Pandemic ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ------Ensuring Equity for Farmers of Color Amid the Pandemic ------Funding Allocation from HHS to BARDA for Therapeutics ------Funding for Vaccine Distribution ------Funding for Vaccine Hesitancy ------Funding the monitoring of COVID-19 in animals ------Supporting Farmers and Strengthening the Food Supply Chain --- Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 Funding for Antimicrobial Resistance (AMR) Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act (Discussion Drafts) --- Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biofuels ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---S.Con.Res.5: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 ------Cruz Amdt. #871 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for Biomass Crop Assistance Program ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for Biorefineries ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding ---Climate Issues & impact on the agriculture, food, and forestry sectors Funding for FDA ---FY 2022 Appropriations ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) - 340B Program Integrity Issues ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 Funding for Health Resources and Services Administration (HRSA) - Countermeasures Injury Compensation Program (CICP) ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 Funding for Health Resources and Services Administration (HRSA) - Vaccine Injury Compensation Program (VICP) ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 Funding for National Institutes of Health ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Renewable Chemicals/Bio-based Products ---FY 2022 Appropriations ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2022 Appropriations ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for 2020-2021 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---FY 2022 Appropriations Funding for the USDA ---H.R.1319: American Rescue Plan Act of 2021 ------Funding the monitoring of COVID-19 in animals ------Supporting Farmers and Strengthening the Food Supply Chain ------Ensuring Equity for Farmers of Color Amid the Pandemic ---S.278: Emergency Relief for Farmers of Color Act of 2021 ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ------USDA Energy Program Funding

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; Natl Institute of Standards & Technology (NIST); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); White House Office; Environmental Protection Agency (EPA)

Bills named: H.R. 133 (117th), H.R. 1319 (117th), S. 278 (117th), S.Con.Res. 5 (117th)